Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Sales 27 390 30 578 31 904 33 177 36 056 38 692
EBITDA 7 022 9 833 8 188 8 142 9 503 10 340
Operating profit (EBIT) 5 976 6 555 7 110 7 149 8 309 9 159
Pre-Tax Profit (EBT) 2 231 2 873 4 077 5 688 8 241 9 175
Net income 353 2 334 3 687 4 206 5 294 7 430
P/E ratio 285x 55,2x 42,2x 32,6x 26,3x 21,1x
EPS ( $ ) 0,20 1,31 2,06 2,42 3,00 3,73
Dividend per Share ( $ ) 1,08 1,16 1,32 1,42 1,54 1,71
Yield 1,88% 1,60% 1,52% 1,80% 1,95% 2,17%
Reference price ( $ ) 57,070 72,330 86,860 78,910 78,910 78,910
Announcement Date 01/24/2018
12:45pm
01/23/2019
12:45pm
01/22/2020
12:30pm
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Debt 18 314 15 480 13 999 10 625 6 332 6 738
Finance - - - - - -
Operating income (EBITDA) 7 022 9 833 8 188 8 142 9 503 10 340
Leverage
(Debt/EBITDA)
2,61x 1,57x 1,71x 1,31x 0,67x 0,65x
Capital Expenditure 1 000 1 394 1 638 1 725 1 851 1 916
Free Cash Flow (FCF) 4 435 4 906 4 498 5 951 6 955 7 620
Book Value Per Share (BVPS) ( $ ) 17,7 17,4 17,6 23,0 24,5 16,4
Cash Flow per Share ( $ ) 3,18 3,56 3,45 3,88 3,85 -
Announcement Date 01/24/2018
12:45pm
01/23/2019
12:45pm
01/22/2020
12:30pm
- - -
Balance Sheet Analysis
Financial data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2020e 2021e
Capitalization 139 153 M $ -
Entreprise Value (EV) 149 777 M $ 145 484 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 32,6x 26,3x
Capitalization / Revenue 4,19x 3,86x
EV / Revenue 4,51x 4,15x
EV / EBITDA 18,4x 15,8x
Yield (DPS / Price) 1,80% 1,95%
Price to book (Price / BVPS) 3,43x 3,22x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 21,5% 23,0%
Operating Leverage (Delta EBIT / Delta Sales) 0,14x 1,87x
Net Margin (Net Profit / Revenue) 12,7% 14,7%
ROA (Net Profit / Asset) 8,09% 10,8%
ROE (Net Profit / Equities) 15,4% 17,6%
Rate of Dividend 58,9% 51,3%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   5,20% 5,13%
Cash Flow / Sales 20,6% 18,8%
Capital Intensity (Assets / Sales) 1,57x 1,36x
Financial Leverage (Net Debt / EBITDA) 1,31x 0,67x
EPS & Dividend